Answers are grounded in this paper and cite their sources.
We recently showed that cellular origin impacts the aggressiveness and the phenotype of acute myeloid leukemia (AML). Direct induction of the MLL-AF9 fusion in various hematopoietic compartments in vivo using a doxycycline (DOX) regulated mouse model (iMLL-AF9) led to an invasive chemoresistant AML expressing several genes known to be involved in epithelial to mesenchymal transition (EMT) in solid cancers. Many of these genes play important roles in migration and invasion and are significantly associated with poor overall survival in AML patients.
No takes yet. Share an insight, caveat, or question.
Stavropoulou et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: